Charles River Laboratories International, Inc. Common Stock (CRL): Acquisition News

CRL – Acquires MPI Research for approximately $800 million in cash.


Key Facts Surrounding This News Item


  • CRL had a POWR Rating of C (Neutral) coming into today.
  • CRL was -0.36% below its 10-Day Moving Average coming into today.
  • CRL was -2.47% below its 20-Day Moving Average coming into today.
  • CRL was -3.95% below its 50-Day Moving Average coming into today.
  • CRL was -5.43% below its 100-Day Moving Average coming into today.
  • CRL was -1.07% below its 200-Day Moving Average coming into today.
  • CRL had returned -6.82% year-to-date leading up to today’s news, versus a -0.57% return from the benchmark S&P 500 during the same period.

More Info About Charles River Laboratories International, Inc. Common Stock (CRL)


Charles River Laboratories provides products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. The company was founded in 1947 and is based in Wilmington, Massachusetts. View our full CRL ticker page with ratings, news, and more.

Try StockNews.com Premium Today!


Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

CRL at a Glance

CRL Current POWR Rating™
Overall POWR Rating™
CRL Current Price $126.85 4.09%
More CRL Ratings, Data, and News

CRL Price Reaction

The day of this event (Feb. 13, 2018)
CRL Closing Price$107.66 5.56%
CRL Volume1,388,000
273.13% from avg
Leading up to this event
CRL 1-mo returnN/A%
After this event
CRL 1-day return7.54%
CRL 3-day return5.66%
CRL 5-day return4.74%

CRL Price Chart



More Charles River Laboratories International, Inc. Common Stock (CRL) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CRL News
Page generated in 1.1457 seconds.